Keystone Financial Group (Kentucky)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.61M | Sell |
14,346
-4,588
| -24% | -$987K | 0.21% | 89 |
|
|
2026
Q1 | $4.11M | Buy |
18,934
+34
| +0.2% | +$7.54K | 0.28% | 65 |
|
|
2025
Q4 | $4.32M | Sell |
18,900
-772
| -4% | -$176K | 0.32% | 61 |
|
|
2025
Q3 | $4.56M | Buy |
19,672
+1,393
| +8% | +$284K | 0.35% | 57 |
|
|
2025
Q2 | $3.39M | Buy |
18,279
+670
| +4% | +$125K | 0.31% | 68 |
|
|
2025
Q1 | $3.69M | Sell |
17,609
-343
| -2% | -$66.7K | 0.38% | 60 |
|
|
2024
Q4 | $3.19M | Buy |
17,952
+161
| +0.9% | +$29.6K | 0.31% | 65 |
|
|
2024
Q3 | $3.51M | Sell |
17,791
-122
| -0.7% | -$22.8K | 0.45% | 43 |
|
|
2024
Q2 | $3.07M | Buy |
17,913
+1,485
| +9% | +$246K | 1.1% | 21 |
|
|
2024
Q1 | $2.99M | Buy |
16,428
+1,665
| +11% | +$287K | 0.44% | 49 |
|
|
2023
Q4 | $2.29M | Sell |
14,763
-455
| -3% | -$66.3K | 0.4% | 56 |
|
|
2023
Q3 | $2.27M | Sell |
15,218
-397
| -3% | -$58.3K | 0.38% | 56 |
|
|
2023
Q2 | $2.1M | Buy |
+15,615
| New | +$2.29M | 0.36% | 59 |
|
|
2022
Q4 | $2.46M | Buy |
15,245
+122
| +0.8% | +$18.7K | 0.49% | 45 |
|
|
2022
Q3 | $2.03M | Buy |
15,123
+694
| +5% | +$99.6K | 0.41% | 56 |
|
|
2022
Q2 | $2.21M | Buy |
14,429
+39
| +0.3% | +$5.96K | 0.44% | 51 |
|
|
2022
Q1 | $2.33M | Buy |
14,390
+309
| +2% | +$44.9K | 0.4% | 57 |
|
|
2021
Q4 | $1.91M | Sell |
14,081
-1,172
| -8% | -$138K | 0.31% | 71 |
|
|
2021
Q3 | $1.65M | Buy |
15,253
+400
| +3% | +$45.7K | 0.3% | 73 |
|
|
2021
Q2 | $1.67M | Buy |
14,853
+278
| +2% | +$31.3K | 0.3% | 76 |
|
|
2021
Q1 | $1.58M | Sell |
14,575
-374
| -3% | -$40K | 0.31% | 75 |
|
|
2020
Q4 | $1.6M | Buy |
14,949
+76
| +0.5% | +$7.3K | 0.33% | 72 |
|
|
2020
Q3 | $1.3M | Sell |
14,873
-562
| -4% | -$52.9K | 0.32% | 70 |
|
|
2020
Q2 | $1.51M | Sell |
15,435
-116
| -0.7% | -$10.2K | 0.41% | 58 |
|
|
2020
Q1 | $1.19M | Buy |
15,551
+452
| +3% | +$38.5K | 0.39% | 62 |
|
|
2019
Q4 | $1.34M | Sell |
15,099
-329
| -2% | -$27.3K | 0.36% | 67 |
|
|
2019
Q3 | $1.17M | Buy |
15,428
+719
| +5% | +$49.3K | 0.36% | 69 |
|
|
2019
Q2 | $1.07M | Buy |
14,709
+1,327
| +10% | +$104K | 0.35% | 71 |
|
|
2019
Q1 | $1.08M | Buy |
13,382
+7,037
| +111% | +$576K | 0.38% | 69 |
|
|
2018
Q4 | $585K | Sell |
6,345
-194
| -3% | -$17.1K | 0.26% | 96 |
|
|
2018
Q3 | $621K | Buy |
6,539
+3,982
| +156% | +$378K | 0.25% | 101 |
|
|
2018
Q2 | $238K | Buy |
+2,557
| New | +$250K | 0.13% | 141 |
|
|
2018
Q1 | – | Sell |
-2,214
| Closed | -$220K | – | 163 |
|
|
2017
Q4 | $220K | Buy |
+2,214
| New | +$209K | 0.14% | 114 |
|
Other funds holding ABBV
Keystone Financial Group (Kentucky)'s ABBV Position: Q2 2026 in Review
Keystone Financial Group (Kentucky) reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $987K and leaving 14,346 shares worth $3.61M. The position accounts for 0.21% of the portfolio, ranked #89.
Keystone Financial Group (Kentucky) first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. The position peaked at $4.56M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Keystone Financial Group (Kentucky) held 14,346 shares of AbbVie worth $3.61M as of Q2 2026.
- Keystone Financial Group (Kentucky) sold 4,588 AbbVie shares in Q2 2026, an estimated $987K.
- AbbVie made up 0.21% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #89 holding.
- Keystone Financial Group (Kentucky) first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
- Keystone Financial Group (Kentucky)'s AbbVie position peaked at $4.56M in Q3 2025.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.